United States News All stories

Nexalin Technology (NASDAQ:NXL) reported the successful completion of an 8-week, single-center, prospective, open-label clinical trial evaluating its proprietary 15 milliamp (mA), 77.5 Hz Deep Intracranial Frequency Stimulation (DIFS™) protocol in adults with generalized anxiety disorder and comorbid insomnia.

Eva Live (NASDAQ:GOAI), a Los Angeles-based artificial intelligence ad-tech company, announced it has signed a non-binding letter of intent (LOI) to acquire Psquared, a profitable performance-marketing agency.

Warner Music Group (NASDAQ:WMG) announced Wednesday that it is acquiring AI attribution startup Sureel AI, a company that has developed patented technology to create “AI DNA” for songs.

Comstock (NASDAQ:CHCI) announced a definitive agreement with Jericho Energy Ventures to establish a joint venture named Oklahoma AI Ventures, aiming to develop mega-scale artificial intelligence data center campuses in rural Oklahoma.

Danaher (NYSE:DHR), a global science and technology innovator, announced that it has completed the acquisition of Masimo (NASDAQ:MASI), a specialty diagnostics provider known for pulse oximetry and other patient monitoring solutions in acute care settings.

Prenetics Global (NASDAQ:PRE), the parent company of the IM8 premium health and longevity brand, reported first-quarter 2026 revenue of $36 million, with IM8 contributing $33.8 million.

HEICO (NYSE:HEI) announced that its Exxelia subsidiary has acquired a 90% stake in CalRamic Technologies, a Reno, Nevada-based manufacturer of high-voltage ceramic capacitors.

T. Rowe Price Group (NASDAQ:TROW) reported month-end assets under management (AUM) of $1.89 trillion as of May 31, 2026.

ParaZero Technologies (NASDAQ:PRZO) announced that it has secured two purchase orders in Israel for its DefendAir Net Pod system, marking a significant step in integrating its autonomous Counter-UAS technology into advanced defense platforms.

Paramount Skydance's (NASDAQ:PSKY) proposed $110 billion acquisition of Warner Bros. Discovery (NASDAQ:WBD) has come under formal scrutiny from the European Union over its financial backing from Middle Eastern sovereign wealth funds, according to a European Commission filing.

Figure Technology Solutions (NASDAQ:FIGR) announced a definitive agreement to acquire Kiavi, an AI-powered lending platform tailored for residential real estate investors, in a transaction valued at $717 million.

Scinai Immunotherapeutics (NASDAQ:SCNI) reported a net profit for the first quarter of fiscal year 2026, driven primarily by a substantial, non-cash accounting gain linked to its recent acquisition of Recipharm Israel.

Cullinan Therapeutics (NASDAQ:CGEM) reported encouraging initial clinical data and outlined expanded development pathways for its portfolio of dual-targeting T-cell engagers, marking an expansion for the oncology-focused biotech into the autoimmune space.

Artelo Biosciences (NASDAQ:ARTL) announced encouraging human metabolite identification and profiling data for its lead drug candidate, ART26.12, as the biotechnology company aims to de-risk the development of its novel non-opioid pain therapy.

Organon (NYSE:OGN) announced that the US Food and Drug Administration (FDA) has approved its supplemental Biologics License Application (sBLA) for Tofidence, expanding the therapeutic indications of the drug within the competitive US biosimilars market.

Core & Main (NYSE:CNM) reported improved financial results for the first quarter of fiscal year 2026, supported by reliable infrastructure demand and active cost navigation in an otherwise mixed industrial environment.

Nvni Group (NASDAQ:NVNI) announced substantial progress toward completing its acquisition of a 51% controlling interest in the holding company operating Beyondsoft Corporation’s consulting and services business across the United States, Brazil, and Singapore.

Tecnoglass (NYSE:TLGS) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.15 per share for the second quarter of 2026.

Harrow (NASDAQ:HROW) announced the formal commercial re-launch of Verkazia, a targeted prescription therapy for vernal keratoconjunctivitis (VKC), an underdiagnosed but severe chronic allergic eye disease that primarily affects children.

Chewy (NYSE:CHWY) delivered a strong financial performance for the first quarter of fiscal year 2026, characterized by robust top-line growth and a significant increase in profitability despite a dynamic broader consumer environment.

APA Corporation (NASDAQ:APA) announced an agreement to acquire Savant Alaska for approximately $70 million in upfront cash, moving to lock down strategic midstream and field infrastructure on Alaska's eastern North Slope.

Opera (NASDAQ:OPRA) announced that its Board of Directors has declared a semi-annual cash dividend of $0.40 per share for holders of its ordinary shares and American Depositary Shares (ADSs).

Lazard (NYSE:LAZ) reported preliminary assets under management (AUM) of approximately $284.8 billion as of May 31, 2026.

J.Jill (NYSE:JILL) reported a 6% decline in net sales for the first quarter of fiscal 2026, falling to $144.4 million from $153.6 million in the year-ago period.